Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,34
USD
|
+6,35%
|
|
+2,29%
|
+14,53%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
119,3
|
132,5
|
164,1
|
67,41
|
73,02
|
100,1
|
-
|
-
|
Bedrijfswaarde
1 |
101,9
|
116,2
|
133,6
|
19,16
|
73,02
|
78,86
|
112,5
|
128,7
|
K/w-verhouding
|
-3,58
x
|
-7,03
x
|
275
x
|
-2,04
x
|
-2,21
x
|
-2,55
x
|
-2,31
x
|
-2,31
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
54,9
x
|
16,8
x
|
5,55
x
|
50,8
x
|
8,88
x
|
36,5
x
|
13,6
x
|
3,81
x
|
Bedrijfswaarde/omzet
|
46,9
x
|
14,7
x
|
4,52
x
|
14,4
x
|
8,88
x
|
28,8
x
|
15,3
x
|
4,9
x
|
Bedrijfswaarde/EBITDA
|
-3.385.883
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-3.760.800
x
|
-
|
-12.451.964
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
41.150
|
48.354
|
59.667
|
60.191
|
62.409
|
74.721
|
-
|
-
|
Referentieprijs
2 |
2,900
|
2,740
|
2,750
|
1,120
|
1,170
|
1,340
|
1,340
|
1,340
|
Datum van publicatie
|
11/03/20
|
10/03/21
|
10/03/22
|
9/03/23
|
12/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2,173
|
7,894
|
29,58
|
1,327
|
8,226
|
2,743
|
7,358
|
26,26
|
EBITDA
|
-30,09
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-30,3
|
-17,94
|
-0,627
|
-30,28
|
-24,84
|
-34,98
|
-37,44
|
-32,52
|
Operationele Marge
|
-1.394,57%
|
-227,2%
|
-2,12%
|
-2.281,61%
|
-302,02%
|
-1.275,36%
|
-508,85%
|
-123,81%
|
Resultaat voor belastingen (EBT)
1 |
-30,77
|
-18,21
|
0,376
|
-32,95
|
-32,48
|
-39,72
|
-44,99
|
-48,09
|
Nettowinst (verlies)
1 |
-30,77
|
-18,21
|
0,376
|
-32,95
|
-32,48
|
-39,65
|
-43,04
|
-44,68
|
Nettomarge
|
-1.416,01%
|
-230,68%
|
1,27%
|
-2.482,82%
|
-394,91%
|
-1.445,75%
|
-585,05%
|
-170,13%
|
WPA
2 |
-0,8100
|
-0,3900
|
0,0100
|
-0,5500
|
-0,5300
|
-0,5260
|
-0,5800
|
-0,5800
|
Free Cash Flow
|
-27,09
|
-
|
-10,73
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-1.246,8%
|
-
|
-36,29%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/20
|
10/03/21
|
10/03/22
|
9/03/23
|
12/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
3,074
|
25,69
|
0,347
|
0,384
|
0,266
|
0,33
|
0,004
|
1,018
|
0,859
|
6,345
|
0,6812
|
0,6842
|
0,6872
|
0,6902
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-4,889
|
18,71
|
-7,646
|
-7,837
|
-6,724
|
-8,07
|
-7,605
|
-7,27
|
-7,054
|
-2,915
|
-8,561
|
-8,723
|
-8,5
|
-8,602
|
-
|
Operationele Marge
|
-159,04%
|
72,83%
|
-2.203,46%
|
-2.040,89%
|
-2.527,82%
|
-2.445,45%
|
-190.125%
|
-714,15%
|
-821,19%
|
-45,94%
|
-1.256,66%
|
-1.274,83%
|
-1.236,74%
|
-1.246,14%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-4,887
|
18,71
|
-7,644
|
-7,813
|
-7,827
|
-9,663
|
-9,28
|
-9,106
|
-9,267
|
-4,832
|
-9,964
|
-10,14
|
-9,925
|
-10,01
|
-
|
Nettowinst (verlies)
1 |
-4,887
|
18,71
|
-7,644
|
-7,813
|
-7,827
|
-9,663
|
-9,28
|
-9,106
|
-9,267
|
-4,832
|
-10
|
-10,22
|
-9,903
|
-9,801
|
-
|
Nettomarge
|
-158,98%
|
72,83%
|
-2.202,88%
|
-2.034,64%
|
-2.942,48%
|
-2.928,18%
|
-232.000%
|
-894,5%
|
-1.078,81%
|
-76,15%
|
-1.468,24%
|
-1.493,14%
|
-1.440,9%
|
-1.419,89%
|
-
|
WPA
2 |
-0,0800
|
0,3100
|
-0,1300
|
-0,1300
|
-0,1300
|
-0,1600
|
-0,1500
|
-0,1500
|
-0,1500
|
-0,0800
|
-0,1380
|
-0,1360
|
-0,1260
|
-0,1240
|
-0,1100
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/11/21
|
10/03/22
|
11/05/22
|
9/08/22
|
9/11/22
|
9/03/23
|
12/05/23
|
14/08/23
|
13/11/23
|
12/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
12,3
|
28,6
|
Nettokaspositie
1 |
17,4
|
16,3
|
30,4
|
48,3
|
-
|
21,3
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-27,1
|
-
|
-10,7
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
0,03
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
1,15%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/20
|
10/03/21
|
10/03/22
|
9/03/23
|
12/03/24
|
-
|
-
|
-
|
Laatste slotkoers
1,34
USD Gemiddelde koersdoel
5,4
USD Spread / Gemiddelde doel +302,99% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +14,53% | 100 mln. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,73 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|